"ALERT: This is NOT a COVID testing center. Located on the Nash UNC Health Care campus, patients in our area now have access to UNC’s nationally recognized physicians, as well as its innovative research and groundbreaking clinical trials."

During the past decade, UNC Cancer Care at Nash conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Cancer Care at Nash" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "UNC Cancer Care at Nash" are "Early Breast Cancer" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "UNC Cancer Care at Nash" in a lesser frequency.

Most popular intervention types in "UNC Cancer Care at Nash" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "Endocrine Therapy of Physician's Choice" (1 trials), "Giredestrant" (1 trials), "LHRH Agonist" (1 trials) and "T-DM1" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Cancer Care at Nash" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UNC Cancer Care at Nash". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UNC Cancer Care at Nash, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNC Cancer Care at Nash, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".